Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.

All day every day cells must detect and repair DNA damage. DNA damage comes in several forms, but the most dangerous and the most relevant for radiotherapy is DNA double strand breaks.

Repairing DNA damage is a team game, with a number of proteins coming together to regulate and carry out the repair. These proteins are vital for the repair, but accumulation of too much of these proteins will cause issues such as genome instability, which can promote both tumour genesis and tumour progression.

RING finger protein 8 (RNF8) is an integral part of the DNA repair process, but it must not be allowed to accumulate in a cell.

Kristijan and his group have uncovered how the cell maintains just the right amount of RNF8. A combination of two proteins, p97 and ATX3 work together to adjust levels of RNF8. Inactivation of the p97-ATX3 combination prevents the cells from regulating the amount of RNF8 and makes the cells very sensitive to radiation.

Since many cancers have evolved to rely heavily on the DNA repair that RNF8 facilitates, this suggests an interesting target for cancer therapy. A target that should hurt cancer cells very much more than healthy ones.

 

 

Abhay Narayan Singh, Judith Oehler, Ignacio Torrecilla, Susan Kilgas, Shudong Li, Bruno Vaz, Claire Guérillon, John Fielden, Esperanza HernandezCarralero, Elisa Cabrera, Iain DC Tullis, Mayura Meerang, Paul R Barber, Raimundo Freire, Jason Parsons, Borivoj Vojnovic, Anne E Kiltie, Niels Mailand, Kristijan Ramadan. (2019) The p97–Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8. EMBO J (2019): e102361

https://www.embopress.org/doi/10.15252/embj.2019102361

Similar stories

Lung abnormalities found in long COVID patients with breathlessness

Researchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests.

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

Eileen Parkes secures Clinical Research Career Development Fellowship

Eileen is awarded funding for her research into the tumour microenvironment

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.